Weight-loss Treatment Through Smartphone-assisted Dietary Coaching
Launched by OVIVA AG · Feb 26, 2016
Trial Information
Current as of June 23, 2025
Completed
Keywords
ClinConnect Summary
Recruitment process will be conducted in two parts. During the first part potential participants will be recruited:
* At the obesity centre during the current obesity consultation
* During regularly information events at the obesity centre flyers will be handed out.
* During training courses for general practitioner at the obesity centre flyers will be handed out.
* Through the network Medical AdiNetwork flyers will be send to general practitioner.
* Advertisement: via website Oviva, Berne University of Applied Science, Zentrum für Adipositas- und Stoffwechselmedizin Winterthur (ZAS) GmbH;...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Informed Consent as documented by signature (Appendix Informed Consent Form)
- • Adults (18 years and over; BMI ≥ 27 kg/m2 and ≤ 32 kg/m2) with fluent German
- • Smartphone user (iOS or Android)
- • Capable of sending / receiving text messages and pictures
- Exclusion Criteria:
- • Women who are pregnant or breast feeding
- • Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant,
- • Persons who were on a diet during the last 6 months; take medication for weight loss at any time before, or are enrolled in another weight loss program
- • Persons with nutrition therapy dependent diseases and other serious diseases requiring continuous drug therapy
- • Enrolment of the investigator, his/her family members, employees and other dependent persons.
- • Individuals who will perform the interventions: registered dietitians
About Oviva Ag
Oviva AG is a leading healthcare company dedicated to transforming the management of chronic diseases through innovative digital solutions. Specializing in nutrition and lifestyle interventions, Oviva leverages advanced technology and evidence-based practices to empower patients and healthcare providers in achieving sustainable health outcomes. With a commitment to enhancing the quality of care, Oviva AG conducts clinical trials to validate the efficacy of its programs, ensuring they are grounded in robust scientific research and tailored to meet the needs of diverse patient populations. Through collaboration with healthcare professionals and institutions, Oviva AG aims to redefine the landscape of chronic disease management and improve patient lives globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Winterthur, Zürich, Switzerland
Patients applied
Trial Officials
Karin Haas, Dr.rer.nat.
Study Chair
Bern University of Applied Sciences
Susanne Maurer-Wiesner, Dr.med.
Principal Investigator
Zentrum für Adipositas- und Stoffwechselmedizin Winterthur GmbH
Kai Eberhardt, Dr.sci.ETH
Study Director
Oviva AG
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials